Tomas Vita1, Christoph Gräni2, Siddique A Abbasi1, Tomas G Neilan3, Ethan Rowin1, Kyoichi Kaneko2, Otavio Coelho-Filho2, Eri Watanabe1, Francois-Pierre Mongeon4, Hoshang Farhad2, Carlos Henrique Rassi2, Yuna L Choi2, Kathleen Cheng2, Michael M Givertz2, Ron Blankstein5, Michael Steigner1, Ayaz Aghayev1, Michael Jerosch-Herold1, Raymond Y Kwong6. 1. Noninvasive Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 2. Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 3. Cardiac MR PET CT Program and Division of Cardiology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. 4. Department of Medicine, Montreal Heart Institute, Université de Montréal, Montréal, Quebec, Canada. 5. Noninvasive Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. 6. Noninvasive Cardiovascular Imaging Program, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address: rykwong@bwh.harvard.edu.
Abstract
OBJECTIVES: In patients with nonischemic dilated cardiomyopathy (NIDCM), native T1, partition coefficient (λGd), and extracellular volume fraction (ECV) mapping may offer prognostic values beyond late gadolinium enhancement (LGE), by scaling the range of myocardial changes. BACKGROUND: In patients with NIDCM, LGE is seen in 30% of patients and it indicates adverse prognosis. METHODS: The study mapped 6 anatomical locations using all 4 cardiac magnetic resonance (CMR) tissue-characterizing methods and associated with outcome. The authors performed T1 mapping of the myocardium and the blood pool, before and serially after contrast injection, using a Look-Locker cine gradient-echo technique to obtain T1 and the corresponding reciprocal R1 values. λGd values were derived from the slopes of the least-squares regression lines for myocardial versus blood R1, then adjusted to serum hematocrit to yield ECV. RESULTS: Consecutive 240 NIDCM patients (49 ± 16 years of age; 38% women) underwent CMR for cardiac function, LGE, native T1, λGd, and ECV. After a median of 3.8 years, 36 (15%) experienced major adverse cardiac events (MACE), including 22 heart failure hospitalizations and 14 deaths. Nonischemic LGE was detected in 34%, whereas ECV was elevated (≥1 location) in 58%. Comparing the 4 methods, mean ECV and λGd both demonstrated strong association with MACE (both p < 0.001). In contrast to native T1 and LGE, ECV values from all 6 locations were associated with MACE and death, with the anteroseptum being the most significant (p < 0.0001). The number of abnormal ECV locations correlated linearly with annual MACE rates (p = 0.0003). Mean ECV was the only predictor to enter a prognostic model that contained age, sex, New York Heart Association functional class, and left ventricular ejection fraction. For every 10% increase, mean ECV portended to a 2.8-fold adjusted increase risk to MACE (p < 0.001). CONCLUSIONS: In this study of patients with NIDCM, mapping the myocardial extent of abnormality using ECV offers prognostication toward heart failure outcomes incremental to LGE or native T1 mapping.
OBJECTIVES: In patients with nonischemic dilated cardiomyopathy (NIDCM), native T1, partition coefficient (λGd), and extracellular volume fraction (ECV) mapping may offer prognostic values beyond late gadolinium enhancement (LGE), by scaling the range of myocardial changes. BACKGROUND: In patients with NIDCM, LGE is seen in 30% of patients and it indicates adverse prognosis. METHODS: The study mapped 6 anatomical locations using all 4 cardiac magnetic resonance (CMR) tissue-characterizing methods and associated with outcome. The authors performed T1 mapping of the myocardium and the blood pool, before and serially after contrast injection, using a Look-Locker cine gradient-echo technique to obtain T1 and the corresponding reciprocal R1 values. λGd values were derived from the slopes of the least-squares regression lines for myocardial versus blood R1, then adjusted to serum hematocrit to yield ECV. RESULTS: Consecutive 240 NIDCMpatients (49 ± 16 years of age; 38% women) underwent CMR for cardiac function, LGE, native T1, λGd, and ECV. After a median of 3.8 years, 36 (15%) experienced major adverse cardiac events (MACE), including 22 heart failure hospitalizations and 14 deaths. Nonischemic LGE was detected in 34%, whereas ECV was elevated (≥1 location) in 58%. Comparing the 4 methods, mean ECV and λGd both demonstrated strong association with MACE (both p < 0.001). In contrast to native T1 and LGE, ECV values from all 6 locations were associated with MACE and death, with the anteroseptum being the most significant (p < 0.0001). The number of abnormal ECV locations correlated linearly with annual MACE rates (p = 0.0003). Mean ECV was the only predictor to enter a prognostic model that contained age, sex, New York Heart Association functional class, and left ventricular ejection fraction. For every 10% increase, mean ECV portended to a 2.8-fold adjusted increase risk to MACE (p < 0.001). CONCLUSIONS: In this study of patients with NIDCM, mapping the myocardial extent of abnormality using ECV offers prognostication toward heart failure outcomes incremental to LGE or native T1 mapping.
Authors: H Arheden; M Saeed; C B Higgins; D W Gao; J Bremerich; R Wyttenbach; M W Dae; M F Wendland Journal: Radiology Date: 1999-06 Impact factor: 11.105
Authors: Paul A Heidenreich; Nancy M Albert; Larry A Allen; David A Bluemke; Javed Butler; Gregg C Fonarow; John S Ikonomidis; Olga Khavjou; Marvin A Konstam; Thomas M Maddox; Graham Nichol; Michael Pham; Ileana L Piña; Justin G Trogdon Journal: Circ Heart Fail Date: 2013-04-24 Impact factor: 8.790
Authors: Tomas G Neilan; Otavio R Coelho-Filho; Stephan B Danik; Ravi V Shah; John A Dodson; Daniel J Verdini; Michifumi Tokuda; Caroline A Daly; Usha B Tedrow; William G Stevenson; Michael Jerosch-Herold; Brian B Ghoshhajra; Raymond Y Kwong Journal: JACC Cardiovasc Imaging Date: 2013-08-08
Authors: Faiez Zannad; Wendy Gattis Stough; Bertram Pitt; John G F Cleland; Kirkwood F Adams; Nancy L Geller; Christian Torp-Pedersen; Bridget-Anne Kirwan; Ferenc Follath Journal: Eur Heart J Date: 2008-02 Impact factor: 29.983
Authors: T J Wu; J J Ong; C Hwang; J J Lee; M C Fishbein; L Czer; A Trento; C Blanche; R M Kass; W J Mandel; H S Karagueuzian; P S Chen Journal: J Am Coll Cardiol Date: 1998-07 Impact factor: 24.094
Authors: Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer Journal: Eur Heart J Date: 2016-05-20 Impact factor: 29.983
Authors: James C Moon; Daniel R Messroghli; Peter Kellman; Stefan K Piechnik; Matthew D Robson; Martin Ugander; Peter D Gatehouse; Andrew E Arai; Matthias G Friedrich; Stefan Neubauer; Jeanette Schulz-Menger; Erik B Schelbert Journal: J Cardiovasc Magn Reson Date: 2013-10-14 Impact factor: 5.364
Authors: Erik B Schelbert; Kayla M Piehler; Karolina M Zareba; James C Moon; Martin Ugander; Daniel R Messroghli; Uma S Valeti; Chung-Chou H Chang; Sanjeev G Shroff; Javier Diez; Christopher A Miller; Matthias Schmitt; Peter Kellman; Javed Butler; Mihai Gheorghiade; Timothy C Wong Journal: J Am Heart Assoc Date: 2015-12-18 Impact factor: 5.501
Authors: Daniel R Messroghli; James C Moon; Vanessa M Ferreira; Lars Grosse-Wortmann; Taigang He; Peter Kellman; Julia Mascherbauer; Reza Nezafat; Michael Salerno; Erik B Schelbert; Andrew J Taylor; Richard Thompson; Martin Ugander; Ruud B van Heeswijk; Matthias G Friedrich Journal: J Cardiovasc Magn Reson Date: 2017-10-09 Impact factor: 5.364
Authors: Vassilios S Vassiliou; Katharina Wassilew; Donnie Cameron; Ee Ling Heng; Evangelia Nyktari; George Asimakopoulos; Anthony de Souza; Shivraman Giri; Iain Pierce; Andrew Jabbour; David Firmin; Michael Frenneaux; Peter Gatehouse; Dudley J Pennell; Sanjay K Prasad Journal: MAGMA Date: 2017-06-12 Impact factor: 2.310
Authors: Ernesto Di Cesare; Scipione Carerj; Anna Palmisano; Maria Ludovica Carerj; Federica Catapano; Davide Vignale; Annamaria Di Cesare; Gianluca Milanese; Nicola Sverzellati; Marco Francone; Antonio Esposito Journal: Radiol Med Date: 2020-07-16 Impact factor: 3.469
Authors: Ayako Seno; Panagiotis Antiochos; Helena Lichtenfeld; Eva Rickers; Iqra Qamar; Yin Ge; Ron Blankstein; Michael Steigner; Ayaz Aghayev; Michael Jerosch-Herold; Raymond Y Kwong Journal: J Am Heart Assoc Date: 2022-01-13 Impact factor: 6.106
Authors: Issa Pour-Ghaz; Mark Heckle; Ikechukwu Ifedili; Sharif Kayali; Christopher Nance; Rajesh Kabra; Sunil K Jha; John L Jefferies; Yehoshua C Levine Journal: Curr Cardiol Rev Date: 2022